Roy L Johnson

US Patent:

6407244, Jun 18, 2002

Filed:

Jan 26, 2000

Appl. No.:

09/491712

Inventors:

Madiraju S. R. Murthy - Brossard, CA
Nancy A. E. Steenaart - Dorval, CA
Roy A. Johnson - Sausalito CA
Gordon C. Shore - Montreal, CA

Assignee:

Gemin X Biotechnologies Inc. - Montreal

International Classification:

C07D20952

US Classification:

5462767, 514277, 514339, 514414, 514451, 514459, 514460, 5462784, 548406, 548468

Abstract:

The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

US Patent:

7144912, Dec 5, 2006

Filed:

Jul 18, 2002

Appl. No.:

10/484652

Inventors:

Roy A. Johnson - Sausalito CA, US
Giorgio Attardo - Laval, CA

Assignee:

Gemin X Biotechnologies Inc. - Montreal

International Classification:

A61K 31/403
C07D 487/00
C07D 209/02
C07D 209/04

US Classification:

514410, 514414, 548421, 548466

Abstract:

The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for causing immunosuppression. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing an autoimmune disease.

US Patent:

7491745, Feb 17, 2009

Filed:

Oct 16, 2006

Appl. No.:

11/581920

Inventors:

Giorgio Attardo - Laval, CA
Roy A. Johnson - Sausalito CA, US

Assignee:

Gemin X Pharmaceuticals Canada Inc.

International Classification:

A61K 31/40

US Classification:

514424

Abstract:

The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

US Patent:

20030009032, Jan 9, 2003

Filed:

Apr 4, 2002

Appl. No.:

10/116094

Inventors:

Madiraju Murthy - Brossard, CA
Nancy Steenaart - Dorval, CA
Roy Johnson - Sausalito CA, US
Gordon Shore - Montreal, CA

International Classification:

C 07D 4 3/14
C07F007/02

US Classification:

546/277400, 548/406000, 548/465000

Abstract:

The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

US Patent:

20040014987, Jan 22, 2004

Filed:

Mar 19, 2003

Appl. No.:

10/392202

Inventors:

Madiraju Murthy - Brossard, CA
Nancy Steenaart - Dorval, CA
Roy Johnson - Sausalito CA, US
Gordon Shore - Montreal, CA

Assignee:

Gemin X Biotechnologies Inc.

International Classification:

C 07D 4 3/14

US Classification:

548/518000

Abstract:

The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.

US Patent:

58836390, Mar 16, 1999

Filed:

Jul 3, 1997

Appl. No.:

8/887828

Inventors:

Thomas J. Walton - Colorado Springs CO
Kipper K. Fulghum - Colorado Springs CO
Thomas R. Batcha - Colorado Springs CO
Michael T. Juran - Highlands Ranch CO
Eric J. Kuzara - Colorado Springs CO
Thomas F. Kraemer - Corvalis OR
Roy L. Johnson - Fort Collins CO

Assignee:

Hewlett-Packard Company - Palo Alto CA

International Classification:

G06T 100

US Classification:

345473

Abstract:

A system for providing a simple, easy to learn and flexible means of creating user interfaces to products under development without the need of a programming language or the need to learn a large set of complicated commands. The Visual Software Engineering ("VSE") system of the invention uses a simple concept of defining both input to and output from graphical objects in an object-oriented system by providing examples of what the user desires the graphical object to do. This technique is referred to herein as "animation by example". In accordance with this process, the user creates a user interface by drawing the user interface with a graphics editor and then defining the output behavior (i. e. , graphics manipulation) of the user interface components by showing each state or frame as an animation. This is accomplished by changing the object using a graphic editor function such as move or rotate and storing each of the frames with the object as a behavior state.